Try our beta test site
801 studies found for:    vaccines [CONDITION] OR vaccines [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers
Condition: Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon
Intervention: Drug: Ad-sig-hMUC-1/ecdCD40L vector vaccine
22 Recruiting DC Vaccination in CML
Condition: Myeloid Leukemia, Chronic
Intervention: Biological: DC vaccine
23 Recruiting Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis
Conditions: Hepatitis B;   Cirrhosis;   Awaiting Organ Transplant
Intervention: Biological: HBV vaccine
24 Recruiting Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Biological: DC vaccine;   Drug: Dasatinib
25 Recruiting Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates
Conditions: Hepatitis;   Hepatitis B;   Liver Diseases;   Digestive System Diseases
Intervention: Biological: 10μg/0.5ml recombinant hepatitis B vaccine
26 Recruiting Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
Conditions: Intussusception;   Rotavirus Infections
Interventions: Drug: Rotarix®,;   Drug: Rotarix®, with other routine vaccines;   Drug: RotaTeq®,;   Drug: RotaTeq®, with other routine vaccines
27 Recruiting Phase 3 Trial of Serbian Seasonal Influenza Vaccine
Condition: Influenza
Interventions: Biological: Seasonal Influenza Vaccine;   Other: Phosphate Buffered Saline
28 Recruiting Pilot Trial of Type I-Polarized Autologous Dendritic Cell Vaccine Incorporating Tumor Blood Vessel Antigen-Derived Peptides in Patients With Metastatic Breast Cancer
Conditions: Breast Cancer;   Metastatic Breast Cancer
Interventions: Biological: tumor blood vessel antigen peptide-pulsed alpha-type-1 polarized dendritic cell vaccine;   Drug: gemcitabine hydrochloride
29 Recruiting Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults
Condition: Rabies
Intervention: Biological: rabies vaccine
30 Recruiting Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)
Conditions: Brain Cancer;   Neoplasm Metastases
Intervention: Biological: Personalized cellular vaccine
31 Recruiting Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam
Condition: Pneumococcal Vaccines
Interventions: Biological: PCV10;   Biological: PCV13
32 Recruiting INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure
Conditions: Heart Failure;   Myocardial Infarction
Interventions: Biological: High Dose Trivalent Influenza Vaccine;   Biological: Standard Dose Quadrivalent Influenza Vaccine
33 Not yet recruiting Evaluation of the Implementation and Effectiveness of IPP-HPV
Condition: HPV Vaccination
Interventions: Drug: HPV vaccine;   Behavioral: Inpatient Postpartum HPV Immunization Quality Improvement Program
34 Recruiting Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine
Conditions: Encephalitis, Japanese;   Measles;   Mumps;   Rubella
Interventions: Biological: CD-JEV;   Biological: MMR
35 Recruiting Vaccination of Stage IV NSCLC Patients With a Carbohydrate Mimotope Vaccine
Condition: Lung Neoplasms
Interventions: Biological: P10s-PADRE vaccine;   Biological: Placebo
36 Recruiting Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.
Conditions: Malignant Melanoma;   Adjuvant Drug Therapy;   Vaccin Therapy
Intervention: Biological: Autologous Dendritic Cell vaccine
37 Recruiting Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients
Condition: Herpes Zoster
Intervention: Biological: Zostavax vaccine
38 Recruiting Imiquimod and Influenza Vaccine for Immunocompromised Patients
Condition: Influenza Vaccine
Interventions: Biological: Intanza;   Biological: Mutagrip;   Drug: Aldara
39 Not yet recruiting Synchronized Immunization NotifiCations
Condition: Vaccination
Intervention: Behavioral: Electronic immunization alert
40 Recruiting Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Conditions: Meningitis;   Meningococcal Meningitis
Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate;   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.